The 60th anniversary of the discovery of the Epstein-Barr virus, the most common viral infection in humans, falls on 28 March. This virus was initially found in connection with a rare cancer in Africa but is now known to play a role in 1% of cancers and diseases like multiple sclerosis. Lawrence Young, a professor of molecular oncology at Warwick Medical School, recounts the history of the virus and explains how studying it could lead to better prevention and treatment for cancer and other illnesses.
The Epstein-Barr virus, discovered 60 years ago, is a prevalent viral infection in humans. Initially identified with a rare cancer in Africa, it is now recognized to be linked to various cancers and autoimmune diseases. Lawrence Young, professor of molecular oncology at Warwick Medical School, discusses the significance of understanding this virus in relation to the prevention and treatment of diseases like cancer and multiple sclerosis.
On 28 March, the 60th anniversary of the discovery of the Epstein-Barr virus will be commemorated. This virus, which is the most common viral infection in humans, was first encountered in connection with a rare cancer in Africa. Today, it is known to be associated with a variety of cancers and autoimmune diseases like multiple sclerosis. Lawrence Young, professor of molecular oncology at Warwick Medical School, sheds light on the history of this virus and its potential implications for preventing and treating diseases such as cancer.